Nonsteroidal anti-inflammatory drugs and the heart: what is the danger? (Q37133897)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18401215 AND SRC:MED&resulttype=core&format=json

5 January 2020

review article

1 reference

title

Nonsteroidal anti-inflammatory drugs and the heart: what is the danger? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18401215 AND SRC:MED&resulttype=core&format=json

5 January 2020

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18401215 AND SRC:MED&resulttype=core&format=json

5 January 2020

author name string

Debabrata Mukherjee

series ordinal

1

1 reference

18 August 2017

publication date

1 March 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18401215 AND SRC:MED&resulttype=core&format=json

5 January 2020

published in

Congestive Heart Failure

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18401215 AND SRC:MED&resulttype=core&format=json

5 January 2020

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18401215 AND SRC:MED&resulttype=core&format=json

5 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18401215 AND SRC:MED&resulttype=core&format=json

5 January 2020

page(s)

75-82

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18401215 AND SRC:MED&resulttype=core&format=json

NSAIDs and gastrointestinal complications: new clinical challenges

5 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111/J.1751-7133.2008.07453.X

Selective cyclooxygenase-2 (COX-2) inhibitors and potential risk of cardiovascular events.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1751-7133.2008.07453.X

Understanding NSAIDs: from aspirin to COX-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1751-7133.2008.07453.X

Hypoxia induces cyclooxygenase-2 via the NF-kappaB p65 transcription factor in human vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1751-7133.2008.07453.X

Risk of cardiovascular events associated with selective COX-2 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1751-7133.2008.07453.X

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1751-7133.2008.07453.X

Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1751-7133.2008.07453.X

Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1751-7133.2008.07453.X

Failing the public health--rofecoxib, Merck, and the FDA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1751-7133.2008.07453.X

Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1751-7133.2008.07453.X

Arthritis medicines and cardiovascular events--"house of coxibs".

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1751-7133.2008.07453.X

Use of first- and second-generation cyclooxygenase-2-selective nonsteroidal antiinflammatory drugs and risk of acute myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1751-7133.2008.07453.X

A coxib a day won't keep the doctor away

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1751-7133.2008.07453.X

Efficacy and safety of the cyclooxygenase 2 inhibitors parecoxib and valdecoxib in patients undergoing coronary artery bypass surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1751-7133.2008.07453.X

Effects of the cyclooxygenase-2 specific inhibitor valdecoxib versus nonsteroidal antiinflammatory agents and placebo on cardiovascular thrombotic events in patients with arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1751-7133.2008.07453.X

Parecoxib, valdecoxib, and cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1751-7133.2008.07453.X

Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1751-7133.2008.07453.X

Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1751-7133.2008.07453.X

Cyclooxygenase inhibitors and the antiplatelet effects of aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1751-7133.2008.07453.X

Effect of ibuprofen on cardioprotective effect of aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1751-7133.2008.07453.X

Nonsteroidal antiinflammatory drugs and the risk of myocardial infarction in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1751-7133.2008.07453.X

Cardiovascular outcomes in high risk patients with osteoarthritis treated with ibuprofen, naproxen or lumiracoxib

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1751-7133.2008.07453.X

Blood pressure in relation to three candidate genes in a Chinese population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1751-7133.2008.07453.X

Systematic review of trials of the effect of continued use of oral non-selective NSAIDs on blood pressure and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1751-7133.2008.07453.X

The Effects of cyclooxygenase-2 inhibitors and nonsteroidal anti-inflammatory therapy on 24-hour blood pressure in patients with hypertension, osteoarthritis, and type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1751-7133.2008.07453.X

Relationship between COX-2 specific inhibitors and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1751-7133.2008.07453.X

Effects of celecoxib and rofecoxib on blood pressure and edema in patients > or =65 years of age with systemic hypertension and osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1751-7133.2008.07453.X

Cyclooxygenase-2--specific inhibitors and cardiorenal function: a randomized, controlled trial of celecoxib and rofecoxib in older hypertensive osteoarthritis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1751-7133.2008.07453.X

Effects of nabumetone, celecoxib, and ibuprofen on blood pressure control in hypertensive patients on angiotensin converting enzyme inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1751-7133.2008.07453.X

The effect of non-steroidal anti-inflammatory drugs and other commonly used non-narcotic analgesics on blood pressure level in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1751-7133.2008.07453.X

Analgesic use and risk of subsequent hypertension in apparently healthy men

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1751-7133.2008.07453.X

Cyclo-oxygenase-2 inhibitors versus non-selective non-steroidal anti-inflammatory drugs and congestive heart failure outcomes in elderly patients: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1751-7133.2008.07453.X

Anti-rheumatic drug use and risk of hospitalization for congestive heart failure in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1751-7133.2008.07453.X

Ibuprofen protects platelet cyclooxygenase from irreversible inhibition by aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1751-7133.2008.07453.X

Celecoxib and ketoprofen for pain management during tonsillectomy: a placebo-controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1751-7133.2008.07453.X

Risks and Benefits of Celecoxib to Prevent Recurrent Adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1751-7133.2008.07453.X

Risk of Death or Reinfarction Associated With the Use of Selective Cyclooxygenase-2 Inhibitors and Nonselective Nonsteroidal Antiinflammatory Drugs After Acute Myocardial Infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1751-7133.2008.07453.X

Risk of congestive heart failure with nonsteroidal antiinflammatory drugs and selective Cyclooxygenase 2 inhibitors: A class effect?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1751-7133.2008.07453.X